Advertisement

Topics

Sandy Rollman Ovarian Cancer Foundation Company Profile

10:06 EDT 27th May 2018 | BioPortfolio

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength of Sandy Rollman. Sandy passed away from advanced ovarian cancer in May 2000. Prior to diagnosis, Sandy experienced many textbook symptoms. Her symptoms were whispering only no one was listening. The tragic result was that Sandy never had a chance against ovarian cancer.


News Articles [3605 Associated News Articles listed on BioPortfolio]

Sandy Rollman Ovarian Cancer Foundation and World Ovarian Cancer Coalition Partner to Host World Ovarian Cancer Day 2018 on May 8

World Ovarian Cancer Day Strives to Raise Awareness for Ovarian Cancer Today the Sandy Rollman Ovarian Cancer Foundation and the World Ovarian Cancer Foundation joined to cele...

Colleen's Dream Foundation funds ovarian cancer clinical trial

(The Translational Genomics Research Institute) Colleen's Dream Foundation, a Scottsdale-based nonprofit dedicated to supporting ovarian cancer research, recently awarded Translational Genomics Resear...

Ovarian cancer rates set to rise by 55%

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type of cancer are set to greatly increase globally by nearly 55% over the next 20 years. This ...

Researchers Making Inroads Against Ovarian Cancer

THURSDAY, March 29, 2018 -- Ovarian cancer can be tough to beat, particularly if it returns after initial treatment, but new research offers a glimmer of hope. One study found that a new targeted "imm...

Screening for ovarian cancer not recommended

(JAMA Network) The US Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women without symptoms and who are not known to be at high risk (such as those who have...

Ovarian Cancer Rates Decline

Ovarian cancer is the second most common gynecologic cancer, after uterine. Ovarian cancer causes more deaths than any other gynecologic cancer in the U.S., but it accounts for only about 3% of all ca...

Ovarian Cancer Risk May Be Paternally Inherited

A history of ovarian cancer among first-order relatives remains the strongest and best-characterized predictor of ovarian cancer risk and a...

[News] Possible X chromosome-linked transmission of ovarian cancer

A family history of ovarian cancer is the most reliable predictor of a woman developing the disease, but current genetic models do not explain why the sisters of a woman diagnosed with ovarian cancer ...

Drugs and Medications [875 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [6840 Associated PubMed Articles listed on BioPortfolio]

MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.

Ovarian cancer is the most lethal malignancy of the women genital tract. Exploring novel factors involved in the development of ovarian cancer and characterizing the molecular mechanisms by which regu...

Research Summaries: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.

In September 2016, the 11th biennial ovarian cancer research symposium was presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. The 2016 symposium focuse...

LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.

Ovarian cancer is the most frequent cause of death resulting from malignant gynecological tumors. After surgical intervention, cisplatin (DDP) is a major chemotherapy drug for ovarian cancer, but the ...

The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer.

Ovarian cancer is the most lethal gynaecologic cancer. Disease prevention may be the only method to reduce the incidence of ovarian cancer. The Society of Gynecologic Oncology advised that salpingecto...

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Pelvic inflammatory disease (PID) has been associated with ovarian cancer risk. To clarify the role of Chlamydia trachomatis and other infectious agents in the development of ovarian cancer, we evalua...

Clinical Trials [8822 Associated Clinical Trials listed on BioPortfolio]

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as ...

The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot Study

The purpose of this study is to evaluate whether or not a traditional First Nations diet (high protein) and/or a dietary intervention based upon current Canadian dietary recommendations (h...

China Ovarian Cancer BRCA Testing Study

This is a prospective, multi-center, observational study, the primary objective is to evaluate the prevalence of gBRCA/sBRCAm in newly diagnosed ovarian cancer patients and explore ovarian...

Writing About Experiences With Ovarian Cancer

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovari...

M. D. Anderson Symptom Inventory - Ovarian Cancer

The goal of this behavioral research study is to learn more about the kind of symptoms that ovarian cancer patients experience. The Primary Aim is to develop and validate an ovarian-cance...

Companies [2698 Associated Companies listed on BioPortfolio]

Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength ...

Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a fi...

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Ar...

The Catherine Violet Hubbard Foundation

The Catherine Violet Hubbard Foundation, Inc. is a recognized 501(c)(3) organization. The Foundation was created to support charitable, scientific, literary or educational purpose...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes ...

More Information about "Sandy Rollman Ovarian Cancer Foundation" on BioPortfolio

We have published hundreds of Sandy Rollman Ovarian Cancer Foundation news stories on BioPortfolio along with dozens of Sandy Rollman Ovarian Cancer Foundation Clinical Trials and PubMed Articles about Sandy Rollman Ovarian Cancer Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sandy Rollman Ovarian Cancer Foundation Companies in our database. You can also find out about relevant Sandy Rollman Ovarian Cancer Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record